Assignee
JOLLA INST ALLERGY IMMUNOLOG
US·16 granted patents·15 pending applications·416 citations·filing 1992–2014
Top patents by PatentIndex Score
31 records- 0196US7393533B1H3L envelope protein immunization methods and H3L envelope passive protection methodsJOLLA INST ALLERGY IMMUNOLOG·Filed 2005·Granted Jul 1, 2008·51 cites·69 claims
- 0295US8956615B1Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying sameJOLLA INST ALLERGY IMMUNOLOG·Filed 2013·Granted Feb 17, 2015·23 cites·20 claims
- 0395US7291331B1Methods of treating OX40 medicated recall immune responsesJOLLA INST ALLERGY IMMUNOLOG·Filed 2003·Granted Nov 6, 2007·63 cites·54 claims
- 0494US7807156B1Methods of treating OX40 mediated recall immune responsesJOLLA INST ALLERGY IMMUNOLOG·Filed 2007·Granted Oct 5, 2010·26 cites·24 claims
- 0594US7531170B1Methods of treating OX40 mediated recall immune responses and agents useful for identifying sameJOLLA INST ALLERGY IMMUNOLOG·Filed 2006·Granted May 12, 2009·24 cites·40 claims
- 0688US7575745B2Ligand for herpes simplex virus entry mediator and methods of useJOLLA INST ALLERGY IMMUNOLOG·Filed 2006·Granted Aug 18, 2009·10 cites·7 claims
- 0786US7118742B2Ligand for herpes simplex virus entry mediator and methods of useJOLLA INST ALLERGY IMMUNOLOG·Filed 2001·Granted Oct 10, 2006·28 cites·31 claims
- 0886US6998108B1Antibodies to p30 polypeptides and methods making and using sameJOLLA INST ALLERGY IMMUNOLOG·Filed 2000·Granted Feb 14, 2006·14 cites·58 claims
- 0984US7553932B1Methods of treating viral infection with IL-10 receptor antagonistsJOLLA INST ALLERGY IMMUNOLOG·Filed 2006·Granted Jun 30, 2009·21 cites·34 claims
- 1081US5583034AEnhancement of adoptosis using antisense oligonucleotidesJOLLA INST ALLERGY IMMUNOLOG·Filed 1994·Granted Dec 10, 1996·90 cites·14 claims
- 1178US8349320B2Compositions and methods for modulating responses mediated or associated with BTLA activityJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Granted Jan 8, 2013·9 cites·17 claims
- 1264US7186681B2Methods of modulating cell migration using galectin-3JOLLA INST ALLERGY IMMUNOLOG·Filed 2001·Granted Mar 6, 2007·12 cites·21 claims
- 1363US6140467ALigand for herpes simplex virus entry mediator and methods of useJOLLA INST ALLERGY IMMUNOLOG·Filed 1997·Granted Oct 31, 2000·24 cites·14 claims
- 1461US2011171242A1Ligand for herpes simplex virus entry mediator and methods of useJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Application pending·0 cites
- 1560US2010129389A1Methods of modulating hvem, btla and cd160 cis complex response or signaling activity with soluble light polypeptide sequencesJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Application pending·0 cites
- 1659US2009136427A1LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease TreatmentJOLLA INST ALLERGY IMMUNOLOG·Filed 2008·Application pending·0 cites
- 1758US5723582AAntigen-specific human glycosylation inhibiting factorJOLLA INST ALLERGY IMMUNOLOG·Filed 1995·Granted Mar 3, 1998·10 cites·14 claims
- 1858US2013084293A1Histamine-releasing factor (hrf), hrf-receptor and methods of modulating inflammationJOLLA INST ALLERGY IMMUNOLOG·Filed 2012·Application pending·0 cites
- 1957US2006039905A1Galectin 11JOLLA INST ALLERGY IMMUNOLOG·Filed 2005·Application pending·0 cites
- 2057US2011150914A1Compositions and methods for dengue virus (dv) treatment and vaccinationJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Application pending·0 cites
- 2152US2015175979A1Ptprs and proteoglycans in autoimmune diseaseJOLLA INST ALLERGY IMMUNOLOG·Filed 2013·Application pending·0 cites
- 2251US2011038855A1Trail and methods of modulating t cell activity and adaptive immune responses using trailJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Application pending·0 cites
- 2351US2015004189A1Epitopes from allergen proteins and methods and uses for immune response modulationJOLLA INST ALLERGY IMMUNOLOG·Filed 2013·Application pending·0 cites
- 2444US5807714AMethod of production of antigen-specific glycosylation inhibiting factorJOLLA INST ALLERGY IMMUNOLOG·Filed 1995·Granted Sep 15, 1998·4 cites·20 claims
- 2544US5565338ASuppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factorJOLLA INST ALLERGY IMMUNOLOG·Filed 1992·Granted Oct 15, 1996·7 cites·30 claims
- 2643US2015119333A1Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)JOLLA INST ALLERGY IMMUNOLOG·Filed 2013·Application pending·0 cites
- 2740US2009311280A1Novel tnf receptor regulatory domainJOLLA INST ALLERGY IMMUNOLOG·Filed 2005·Application pending·0 cites
- 2838US2013202634A1Dengue Virus (DV) Polypeptide Sequences, T Cell Epitopes and Methods and Uses ThereofJOLLA INST ALLERGY IMMUNOLOG·Filed 2012·Application pending·0 cites
- 2937US2013108602A1Methods and uses of nur77 and nur77 agonists to modulate macrophages and monocytes, and treat inflammation, inflammatory disease and cardiovascular diseaseJOLLA INST ALLERGY IMMUNOLOG·Filed 2012·Application pending·0 cites
- 3035US2016075753A1MODULATION OF REGULATORY T CELL FUNCTION VIA PROTEIN KINASE C-etaJOLLA INST ALLERGY IMMUNOLOG·Filed 2014·Application pending·0 cites
- 3133US2013095127A1METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN)JOLLA INST ALLERGY IMMUNOLOG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when JOLLA INST ALLERGY IMMUNOLOG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →